Safety and Efficacy of RK0202 in Oral Mucositis

Summary

The primary objective of the study is to assess the effect of RK-0202 versus placebo on the incidence and severity of oral mucositis in subjects receiving radiation therapy for head and neck cancer. Concurrent chemotherapy is not allowed in the study.

Timeline

Start

2003-01

Primary completion

—

Completion

2005-12

Drugs

Indications